The group of patients with NAFLD had greater body weight (p = 0.003), greater waist circumference (p < 0.001), higher fasting blood glucose (p = 0.021), higher HbA1c levels (p = 0.028), lower HDL cholesterol levels (p = 0.043), higher triglyceride levels (p = 0.023), higher levels of AST/ALT (p = 0.004) and ALT (p = 0.001). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.